Branded Generics Market Size, Share & Trends Report

Branded Generics Market Size, Share & Trends Analysis Report By Drug Class, By Application, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-943-5
  • Number of Pages: 155
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Market Segmentation

  • Drug Class Outlook (Revenue, USD Billion, 2018 - 2030)
    • Alkylating Agents
    • Antimetabolites
    • Hormones
    • Anti-Hypertensive
    • Lipid Lowering Drugs
    • Anti-Depressants
    • Anti-Psychotics
    • Anti-Epileptics
    • Others
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Oncology
    • Cardiovascular Diseases
    • Neurological Diseases
    • Gastrointestinal Diseases
    • Dermatological Diseases
    • Acute and Chronic Pain
    • Others
  • Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
    • Topical
    • Oral
    • Parenteral
    • Others
  • Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Drug Class Outlook
        • Alkylating Agents
        • Antimetabolites
        • Hormones
        • Anti-Hypertensive
        • Lipid Lowering Drugs
        • Anti-Depressants
        • Anti-Psychotics
        • Anti-Epileptics
        • Others
      • North America Application Outlook
        • Oncology
        • Cardiovascular Diseases
        • Neurological Diseases
        • Gastrointestinal Diseases
        • Dermatological Diseases
        • Acute and Chronic Pain
        • Others
      • North America Route of Administration Outlook
        • Topical
        • Oral
        • Parenteral
        • Others
      • North America Distribution Channel Outlook
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • U.S.
        • U.S. Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • U.S. Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • U.S. Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • U.S. Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Canada
        • Canada Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Canada Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Canada Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Canada Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Europe
      • Europe Drug Class Outlook
        • Alkylating Agents
        • Antimetabolites
        • Hormones
        • Anti-Hypertensive
        • Lipid Lowering Drugs
        • Anti-Depressants
        • Anti-Psychotics
        • Anti-Epileptics
        • Others
      • Europe Application Outlook
        • Oncology
        • Cardiovascular Diseases
        • Neurological Diseases
        • Gastrointestinal Diseases
        • Dermatological Diseases
        • Acute and Chronic Pain
        • Others
      • Europe Route of Administration Outlook
        • Topical
        • Oral
        • Parenteral
        • Others
      • Europe Distribution Channel Outlook
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Germany
        • Germany Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Germany Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Germany Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Germany Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • U.K.
        • U.K. Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • U.K. Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • U.K. Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • U.K. Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • France
        • France Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • France Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • France Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • France Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Italy
        • Italy Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Italy Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Italy Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Italy Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Spain
        • Spain Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Spain Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Spain Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Spain Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Asia Pacific
      • Asia Pacific Drug Class Outlook
        • Alkylating Agents
        • Antimetabolites
        • Hormones
        • Anti-Hypertensive
        • Lipid Lowering Drugs
        • Anti-Depressants
        • Anti-Psychotics
        • Anti-Epileptics
        • Others
      • Asia Pacific Application Outlook
        • Oncology
        • Cardiovascular Diseases
        • Neurological Diseases
        • Gastrointestinal Diseases
        • Dermatological Diseases
        • Acute and Chronic Pain
        • Others
      • Asia Pacific Route of Administration Outlook
        • Topical
        • Oral
        • Parenteral
        • Others
      • Asia Pacific Distribution Channel Outlook
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Japan
        • Japan Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Japan Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Japan Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Japan Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • China
        • China Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • China Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • China Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • China Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • India
        • India Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • India Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • India Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • India Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Australia
        • Australia Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Australia Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Australia Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Australia Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • South Korea
        • South Korea Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • South Korea Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • South Korea Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • South Korea Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Latin America
      • Latin America Drug Class Outlook
        • Alkylating Agents
        • Antimetabolites
        • Hormones
        • Anti-Hypertensive
        • Lipid Lowering Drugs
        • Anti-Depressants
        • Anti-Psychotics
        • Anti-Epileptics
        • Others
      • Latin America Application Outlook
        • Oncology
        • Cardiovascular Diseases
        • Neurological Diseases
        • Gastrointestinal Diseases
        • Dermatological Diseases
        • Acute and Chronic Pain
        • Others
      • Latin America Route of Administration Outlook
        • Topical
        • Oral
        • Parenteral
        • Others
      • Latin America Distribution Channel Outlook
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Brazil
        • Brazil Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Brazil Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Brazil Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Brazil Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Mexico
        • Mexico Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Mexico Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Mexico Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Mexico Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Argentina
        • Argentina Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Argentina Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Argentina Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Argentina Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Middle East and Africa (MEA)
      • Middle East and Africa (MEA) Drug Class Outlook
        • Alkylating Agents
        • Antimetabolites
        • Hormones
        • Anti-Hypertensive
        • Lipid Lowering Drugs
        • Anti-Depressants
        • Anti-Psychotics
        • Anti-Epileptics
        • Others
      • Middle East and Africa (MEA) Application Outlook
        • Oncology
        • Cardiovascular Diseases
        • Neurological Diseases
        • Gastrointestinal Diseases
        • Dermatological Diseases
        • Acute and Chronic Pain
        • Others
      • Middle East and Africa (MEA) Route of Administration Outlook
        • Topical
        • Oral
        • Parenteral
        • Others
      • Middle East and Africa (MEA) Distribution Channel Outlook
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • South Africa
        • South Africa Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • South Africa Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • South Africa Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • South Africa Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Saudi Arabia
        • Saudi Arabia Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • Saudi Arabia Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • Saudi Arabia Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • Saudi Arabia Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • UAE
        • UAE Drug Class Outlook
          • Alkylating Agents
          • Antimetabolites
          • Hormones
          • Anti-Hypertensive
          • Lipid Lowering Drugs
          • Anti-Depressants
          • Anti-Psychotics
          • Anti-Epileptics
          • Others
        • UAE Application Outlook
          • Oncology
          • Cardiovascular Diseases
          • Neurological Diseases
          • Gastrointestinal Diseases
          • Dermatological Diseases
          • Acute and Chronic Pain
          • Others
        • UAE Route of Administration Outlook
          • Topical
          • Oral
          • Parenteral
          • Others
        • UAE Distribution Channel Outlook
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.